Testosterone Replacement Therapy: A Comparison with Non-Medical Approaches

Understanding Testosterone Replacement Therapy and Its Alternatives Clearwater, United States – January 5, 2026 / The Confidence Clinic / Clearwater-based physicians emphasize evidence-based care for ...

What Ascendis Pharma (ASND)'s Phase 2 COACH Combo Data Means For Shareholders

Earlier this week, Ascendis Pharma A/S reported Week 52 topline data from its Phase 2 COACH trial, showing that once-weekly TransCon CNP plus TransCon hGH in children with achondroplasia delivered ...

Northland Power (TSE:NPI) shareholders have endured a 52% loss from investing in the stock five years ago

We think intelligent long term investing is the way to go. But no-one is immune from buying too high. For example ...

Viking Therapeutics, Inc.: Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity

Publication Highlights Impressive Weight Loss of Up to 14.7% from Baseline After 13 Weeks of Treatment; No Plateau Observed VK2735 Currently Being Evaluated in VANQUISH ...